| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| General health | 12 | 2 | |
| Cystic fibrosis | 3 | 0 | |
| Antiphospholipid antibody syndrome | 1 | 0 | |
| Autoimmune hepatitis | 1 | 1 | |
| Blood clot | 1 | 0 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Anxious mood | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 6 |